N04.1

Clinical Causes: Primary glomerular diseases, such as focal segmental glomerulosclerosis (FSGS) and minimal change disease Secondary causes like infections, autoimmune diseases (e.g., lupus), or drug reactions Genetic predispositions affecting kidney structure Underlying conditions that lead to scarring or damage in the glomeruli Injury or trauma to the kidneys

Key Symptoms: Sudden or gradual swelling in the ankles, feet, legs, or around the eyes Excessive protein in the urine, often noticeable as foamy or frothy urine Weight gain due to fluid retention Fatigue and general feeling of tiredness High blood pressure Loss of appetite Changes in urine output, including decreased urine or blood in urine

Diagnosis Path: Diagnosis involves a combination of clinical examination and laboratory tests. These typically include urine tests to detect proteinuria, blood tests to evaluate kidney function and look for underlying causes, and sometimes kidney biopsy to observe the specific pattern of damage in the glomeruli. Imaging studies may be performed to assess kidney size and structure, although they are less definitive for this condition.

Treatment Protocols: Management of nephrotic syndrome with focal and segmental glomerular lesions aims to control symptoms and prevent complications. Treatment strategies often involve medication such as corticosteroids or immunosuppressants to reduce immune-related inflammation. Additionally, medications to lower blood pressure and reduce protein loss, like ACE inhibitors or ARBs, are commonly prescribed. Dietary modifications, including salt restriction and adequate protein intake, may be recommended. Regular monitoring of kidney function and protein levels is crucial to adjust treatment as needed. In some cases, additional therapies or interventions may be necessary depending on the severity and underlying cause.